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Radiolabeled peptides targeted to cholecystokinin/gastrin receptors are promising compounds 
for radiodiagnostics and radiotherapy of some malignancies. Shorter chain derivates of gastrin 
called minigastrins are particularly interesting. The use of these agents is limited by their 
nephrotoxicity caused by accumulation of the radiopeptides in the kidney. The aim of 
the study was to investigate accumulation rate and renal uptake mechanisms of new receptor 
specific peptides from the group of gastrin analogs using in vitro models. The investigation 
was aimed at a comparison of the renal uptake of DOTA-minigastrin 48 (DOTA-MG48) and 
DOTA-minigastin 11 (DOTA-MG11), both labeled with indium-111. In addition, a potential 
influence of the radiolabel on the renal accumulation was also investigated using DOTA-
MG11 labeled with indium-111 or with lutecium-177. A comparison of the renal 
accumulation of the radiolabeled minigastrins with compounds from another group of 





DOTA-TATE was also carried out. To determine contribution of active transport mechanisms 
to the renal accumulation of the radiopeptides, accumulation studies were performed under 
conditions when energy-dependent processes were inhibited. A potential influence of cell 
models on the renal accumulation was also evaluated. For quantitative assessment, the renal 
uptake of the minigastrins was compared with accumulation of substances well-known 








Tc-DMSA). As the experimental cell models were used 
isolated rat renal cells obtained by the perfusion collagenase method from the native tissue 
and renal porcine cell line LLC-PK1 The results demonstrated that 
111
In-DOTA-MG48 was 
accumulated in the renal cells with a lower intensity than 
111
In-DOTA-MG11. Both 
minigastrins were transported into the renal cells probably by passive transport, since 
a participation of active mechanisms was not provable. 
111
In-DOTA-MG11 accumulation 
in the isolated rat renal cells was higher than that of 
177
Lu-DOTA-MG11, but not 
significantly. While 
111
In-DOTA-MG11 was accumulated in the cells in a similar or lower 
rate than the investigated somatostatin derivatives, 
111
In-DOTA-MG48 was captured in 





the accumulation of both minigastrins was significantly lower. The results demonstrate that 
the studied 
111
In-DOTA-MG48 shows relatively low accumulation in renal cells. From that 
point of view it could be a promising compound for further investigations aimed 
at perspective development of a new radiopharmaceutical. 
